Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 388

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 388
---
 the Merger Agreement and to complete the transactions contemplated thereby; |

| • |     | the completion of the transactions contemplated by the Merger Agreement not contravening applicable organizational documents or laws; legal requirements; orders or governmental authorizations; contracts and permits or licenses, registrations and other qualifications; |

| • |     | broker’s fee or commission; and |

| • |     | absence of other representations and warranties. |

The customary representations and warranties made solely by Kineta relate to the following subject matters, among other things:

| • |     | compliance with legal requirements; |

| • |     | employee benefit plans; |

| • |     | employment and labor matters; |

| • |     | environmental matters; |

| • |     | tax matters; |

| • |     | material contracts, including the validity and effectiveness of those contracts and the absence of material breaches of or defaults under those contracts; |

| • |     | insurance; |

| • |     | title to tangible personal property and leasehold interests in leased properties; |

| • |     | intellectual property; |

| • |     | anti-takeover statutes and regulations and absence of a stockholder rights plan; |

| • |     | absence of related person transactions. |

| • |     | compliance with the Foreign Corrupt Practices Act and laws related to export controls and economic sanctions; |

| • |     | compliance with health care laws; and |

| • |     | data privacy and security; |

The customary representations and warranties made solely by TuHURA and Merger Subs relate to the following subject matters, among other things:

| • |     | capitalization and absence of prior operations of Merger Subs; and |

| • |     | TuHURA having sufficient funds available to consummate the Mergers (assuming receipt of the Concurrent Investment). |

Several of the representations, warranties, closing conditions and termination provisions contained in the Merger Agreement are qualified by or refer to the concept of a material adverse effect. For purposes of the 237

Merger Agreement, a “Material Adverse Effect” on Kineta means any event, change, circumstance, occurrence or effect that would, individually or in the aggregate, have a material adverse effect (A) on the assets (taken as a whole), business, financial condition or results of operations of the Company and its subsidiaries, taken as a whole, other than any event, change, circumstance, occurrence or effect arising out of, attributable to or resulting from,